AW
VSTM icon

ACG Wealth’s Verastem VSTM Stock Holding History

ACG Wealth’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-208
Closed -$3K – 998
2022
Q2 		$3K Buy
+208
New +$3.31K ﹤0.01% 802

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ACG Wealth's VSTM Position: Q3 2022 in Review

ACG Wealth sold out of Verastem (VSTM) in Q3 2022, closing a stake of 208 shares — an estimated $3K sold.

ACG Wealth first reported a position in VSTM in Q2 2022 and held it in 1 quarter. The position peaked at $3K in Q2 2022. 109 funds tracked by Wall St. Rank hold VSTM as of Q3 2022.

  • ACG Wealth reported no remaining Verastem position as of Q3 2022 after selling out during the quarter.
  • ACG Wealth sold 208 Verastem shares in Q3 2022, an estimated $3K.
  • ACG Wealth first reported a position in Verastem in Q2 2022 and held it in 1 quarter.
  • ACG Wealth's Verastem position peaked at $3K in Q2 2022.
  • 109 funds tracked by Wall St. Rank held Verastem as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.